Episode 54

For Oncology Nurses: Non-Small Cell Lung Cancer with a ROS1 Fusion — An Interview with Dr Alexander E Drilon

Featuring an interview with Dr Alexander E Drilon, including the following topics:

  • Overview of targetable biomarkers in lung cancer (0:00)
  • Biomarker testing for genomic alterations in lung cancer (5:24)
  • Overview of ROS1 alterations in lung cancer (13:44)
  • Efficacy data with ROS1 inhibitors for lung cancer (17:02)
  • Safety data with ROS1 inhibitors for lung cancer (21:15)
  • Case: A woman in her early 50s with a history of non-small cell lung cancer (NSCLC) undergoes biomarker testing to reveal a ROS1 fusion (28:56)
  • Case: A man in his late teens diagnosed with de novo advanced NSCLC with a ROS1 alteration achieves a dramatic response to therapy (46:16)
  • Case: A woman in her early 60s with a history of ROS1-altered NSCLC receives several ROS1 inhibitors (50:52)

NCPD information and select publications

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for Lung Cancer Update
Lung Cancer Update
This series bridges the gap between research and patient care by providing medical oncologists and hematologists ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

Listen for free